CVS Health executives appear confident the acquisition of Aetna will survive antitrust scrutiny though there may be divestitures where the two sell overlapping Medicare drug coverage.
CVS-Aetna Deal Nears Antitrust OK As Drug Plan Divestitures Loom
CVS Health executives appear confident the acquisition of Aetna will survive antitrust scrutiny though there may be divestitures where the two sell overlapping Medicare drug coverage.